RXST · RxSight, Inc. · Insider Trading
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-09-15 | Weinberg Eric |
See remarks |
Convert↑
|
Common Stock
|
35,168 |
| 2026-09-15 | Weinberg Eric |
See remarks |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
The shares subject to the option were fully vested and exercisable. |
Stock Option (right to buy)
|
35,168 |
| 2026-09-05 | Goldshleger Ilya |
Chief Operating Officer |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.55:1 basis with a post-exchange exercise price of $6.375 per share. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 4, 2024. |
Stock Option (right to buy)
|
92,200 |
| 2026-09-05 | Kurtz Ronald M MD |
Director, President & CEO |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.15:1 basis with a post-exchange exercise price of $6.375 per share. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 9, 2023. |
Stock Option (right to buy)
|
200,000 |
| 2026-09-05 | Kurtz Ronald M MD |
Director, President & CEO |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.55:1 basis with a post-exchange exercise price of $6.375 per share. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 4, 2024. |
Stock Option (right to buy)
|
149,000 |
| 2026-09-05 | Kurtz Ronald M MD |
Director, President & CEO |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean February 27, 2025. |
Stock Option (right to buy)
|
215,000 |
| 2026-09-05 | Goldshleger Ilya |
Chief Operating Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 35,244 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 35,244 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 58,740 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter. |
Stock Option (right to buy)
|
93,984 |
| 2026-09-05 | Wilterding Mark |
Chief Financial Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1:1 basis with a post-exchange exercise price of $6.375 per share. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter. |
Stock Option (right to buy)
|
258,770 |
| 2026-09-05 | Kurtz Ronald M MD |
Director, President & CEO |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.15:1 basis with a post-exchange exercise price of $6.375 per share. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 148,549 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 148,549 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 25,364 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter. |
Stock Option (right to buy)
|
173,913 |
| 2026-09-05 | Weinberg Eric |
See remarks |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.15:1 basis with a post-exchange exercise price of $6.375 per share. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 70,560 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 70,560 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 12,048 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter. |
Stock Option (right to buy)
|
82,608 |
| 2026-09-05 | Weinberg Eric |
See remarks |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.55:1 basis with a post-exchange exercise price of $6.375 per share. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 4, 2024. |
Stock Option (right to buy)
|
92,200 |
| 2026-09-05 | Goldshleger Ilya |
Chief Operating Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the shares subject to the option will vest on February 28, 2027 and the remaining 75% of the shares subject to the option will vest on August 31, 2027. |
Stock Option (right to buy)
|
73,960 |
| 2026-09-05 | Goldshleger Ilya |
Chief Operating Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.55:1 basis with a post-exchange exercise price of $6.375 per share. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 16,129 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 16,129 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 16,129 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter. |
Stock Option (right to buy)
|
32,258 |
| 2026-09-05 | Goldshleger Ilya |
Chief Operating Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.55:1 basis with a post-exchange exercise price of $6.375 per share. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 37,177 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 37,177 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 22,306 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter. |
Stock Option (right to buy)
|
59,483 |
| 2026-09-05 | Goldshleger Ilya |
Chief Operating Officer |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.15:1 basis with a post-exchange exercise price of $6.375 per share. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 9, 2023. |
Stock Option (right to buy)
|
120,000 |
| 2026-09-05 | Goldshleger Ilya |
Chief Operating Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.15:1 basis with a post-exchange exercise price of $6.375 per share. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 89,129 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 89,129 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 15,218 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter. |
Stock Option (right to buy)
|
104,347 |
| 2026-09-05 | Weinberg Eric |
See remarks |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.55:1 basis with a post-exchange exercise price of $6.375 per share. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean August 7, 2024. |
Stock Option (right to buy)
|
50,000 |
| 2026-09-05 | Weinberg Eric |
See remarks |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 35,244 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 35,244 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 58,740 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter. |
Stock Option (right to buy)
|
93,984 |
| 2026-09-05 | Goldshleger Ilya |
Chief Operating Officer |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.55:1 basis with a post-exchange exercise price of $6.375 per share. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean August 7, 2024. |
Stock Option (right to buy)
|
50,000 |
| 2026-09-05 | Goldshleger Ilya |
Chief Operating Officer |
Other↓
Filing footnotes — Stock option (right to buy) (Direct)
On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share. |
Stock option (right to buy)
|
98,367 |
| 2026-09-05 | Wilterding Mark |
Chief Financial Officer |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1:1 basis with a post-exchange exercise price of $6.375 per share. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of January 11, 2026 (the "Vesting Commencement Date"), and the remaining shares subject to the options shall vesting equally monthly on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) over the following three years, such that all of the shares subject to the option shall be fully vested four years from the Vesting Commencement Date. |
Stock Option (right to buy)
|
258,770 |
| 2026-09-05 | Weinberg Eric |
See remarks |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the shares subject to the option will vest on February 28, 2027 and the remaining 75% of the shares subject to the option will vest on August 31, 2027. |
Stock Option (right to buy)
|
65,742 |
| 2026-09-05 | Kurtz Ronald M MD |
Director, President & CEO |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 60,620 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 60,620 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 101,034 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter. |
Stock Option (right to buy)
|
161,654 |
| 2026-09-05 | Weinberg Eric |
See remarks |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean February 27, 2025. |
Stock Option (right to buy)
|
125,000 |
| 2026-09-05 | Weinberg Eric |
See remarks |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.55:1 basis with a post-exchange exercise price of $6.375 per share. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 16,129 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 16,129 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 16,129 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter. |
Stock Option (right to buy)
|
32,258 |
| 2026-09-05 | Goldshleger Ilya |
Chief Operating Officer |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean February 27, 2025. |
Stock Option (right to buy)
|
125,000 |
| 2026-09-05 | Kurtz Ronald M MD |
Director, President & CEO |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.55:1 basis with a post-exchange exercise price of $6.375 per share. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 60,080 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 60,080 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 36,049 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter. |
Stock Option (right to buy)
|
96,129 |
| 2026-09-05 | Kurtz Ronald M MD |
Director, President & CEO |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the shares subject to the option will vest on February 28, 2027 and the remaining 75% of the shares subject to the option will vest on August 31, 2027. |
Stock Option (right to buy)
|
254,751 |
| 2026-09-05 | Weinberg Eric |
See remarks |
Other↓
Filing footnotes — Stock option (right to buy) (Direct)
On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share. |
Stock option (right to buy)
|
87,437 |
| 2026-09-05 | Kurtz Ronald M MD |
Director, President & CEO |
Other↓
Filing footnotes — Stock option (right to buy) (Direct)
On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share. |
Stock option (right to buy)
|
338,819 |
| 2026-09-05 | Weinberg Eric |
See remarks |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.15:1 basis with a post-exchange exercise price of $6.375 per share. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 9, 2023. |
Stock Option (right to buy)
|
95,000 |
| 2026-09-05 | Weinberg Eric |
See remarks |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.55:1 basis with a post-exchange exercise price of $6.375 per share. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 37,177 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 37,177 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 22,306 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter. |
Stock Option (right to buy)
|
59,483 |
| 2026-09-02 | Weinberg Eric |
See remarks |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person. |
Common Stock
|
2,041 |
| 2026-09-02 | Wilterding Mark |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person. |
Common Stock
|
7,765 |
| 2026-09-02 | Kurtz Ronald M MD |
Director, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person. |
Common Stock
|
5,100 |
| 2026-09-02 | Goldshleger Ilya |
Chief Operating Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person. |
Common Stock
|
2,041 |
| 2026-08-31 | Goldshleger Ilya |
Chief Operating Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. |
Common Stock
|
5,370 |
| 2026-08-31 | Weinberg Eric |
See remarks |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan (the "Plan")) through each applicable date, one-sixth (1/6th) of the RSUs subject to the award shall vest on the first Trading Day (as defined in the Plan) on or after each of August 31, 2026, February 28, 2027, August 31, 2027, February 28, 2028, August 31, 2028 and February 28, 2029. |
Restricted Stock Unit
|
5,370 |
| 2026-08-31 | Wilterding Mark |
Chief Financial Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. |
Common Stock
|
20,441 |
| 2026-08-31 | Goldshleger Ilya |
Chief Operating Officer |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan (the "Plan")) through each applicable date, one-sixth (1/6th) of the RSUs subject to the award shall vest on the first Trading Day (as defined in the Plan) on or after each of August 31, 2026, February 28, 2027, August 31, 2027, February 28, 2028, August 31, 2028 and February 28, 2029. |
Restricted Stock Unit
|
5,370 |
| 2026-08-31 | Kurtz Ronald M MD |
Director, President & CEO |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan (the "Plan")) through each applicable date, one-sixth (1/6th) of the RSUs subject to the award shall vest on the first Trading Day (as defined in the Plan) on or after each of August 31, 2026, February 28, 2027, August 31, 2027, February 28, 2028, August 31, 2028 and February 28, 2029. |
Restricted Stock Unit
|
13,425 |
| 2026-08-31 | Wilterding Mark |
Chief Financial Officer |
Convert↓
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one eighth (1/8th) of the shares subject to the RSU award vested on February 28, 2026, and one eighth (1/8th) of the shares subject to the RSU award will vest every six months thereafter on the last day of February and the last day of August over a four-year period. |
Restricted Stock Unit
|
20,441 |
| 2026-08-31 | Kurtz Ronald M MD |
Director, President & CEO |
Convert↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. |
Common Stock
|
13,425 |
| 2026-08-31 | Weinberg Eric |
See remarks |
Convert↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Includes 1,668 shares of Common Stock acquired October 31, 2025 under the Issuer's 2021 Employee Stock Purchase Plan. |
Common Stock
|
5,370 |
| 2026-07-24 | Mottiwala Aziz |
Chief Commercial Officer |
Award↑
Filing footnotes — Restricted Stock Unit (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2026 Inducement Equity Incentive Plan) through each applicable date, twenty percent (20%) of the RSUs subject to the award shall vest on the one year anniversary of the grant date, twenty percent (20%) of the RSUs subject to the award shall vest on the two year anniversary of the grant date, and 60% of the RSUs subject to the award shall vest on the three year anniversary of the grant date. |
Restricted Stock Unit
|
2,312,138 |
| 2026-07-24 | Mottiwala Aziz |
Chief Commercial Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2026 Inducement Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date, and, thereafter, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean July 24, 2026. |
Stock Option (right to buy)
|
571,286 |
| 2026-06-17 | Tammenoms Bakker Juliet |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date of the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 17, 2026. |
Common Stock
|
37,037 |
| 2026-06-17 | Warner Robert Keith |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date of the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 17, 2026. |
Common Stock
|
37,037 |
| 2026-06-17 | Maniar Shweta |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date of the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 17, 2026. |
Common Stock
|
37,037 |
| 2026-06-17 | Fountain Tamara |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date of the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 17, 2026. |
Common Stock
|
37,037 |